GetTopicDetailResponse(id=a8e7852012, topicName=HBsAg清除, introduction=HBsAg清除, content=null, image=null, comments=0, allHits=971, url=https://h5.medsci.cn/topic?id=8520, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=61523, tagList=[TagDto(tagId=61523, tagName=HBsAg清除)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2223017, encodeId=f895222301e06, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=a8e7852012' target=_blank style='color:#2F92EE;'>#HBsAg清除#</a>, objectTitle=【期刊導讀】薈萃分析：免疫耐受期患者抗病毒治療有利于實現(xiàn)HBV DNA陰轉及HBsAg清除, objectType=article, longId=840600, objectId=939f8406000f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240614/1718353750998_5579292.jpg, objectUrl=/article/show_article.do?id=939f8406000f, replyNumber=0, likeNumber=101, createdTime=2024-08-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=939f8406000f, moduleTitle=【期刊導讀】薈萃分析：免疫耐受期患者抗病毒治療有利于實現(xiàn)HBV DNA陰轉及HBsAg清除, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=939f8406000f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215832, encodeId=7be722158320b, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=a8e7852012' target=_blank style='color:#2F92EE;'>#HBsAg清除#</a> <a href='/topic/show?id=7e7711686465' target=_blank style='color:#2F92EE;'>#PEG-IFNα#</a> <a href='/topic/show?id=da8c116865b7' target=_blank style='color:#2F92EE;'>#IFN-γ+#</a>, objectTitle=【期刊導讀】高志良教授團隊：PEG-IFNα治療期間ALT升高有助于慢乙肝患者HBsAg清除的免疫機制探索, objectType=article, longId=835357, objectId=4d4983535e97, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240613/1718249714103_8538692.png, objectUrl=/article/show_article.do?id=4d4983535e97, replyNumber=0, likeNumber=129, createdTime=2024-07-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4d4983535e97, moduleTitle=【期刊導讀】高志良教授團隊：PEG-IFNα治療期間ALT升高有助于慢乙肝患者HBsAg清除的免疫機制探索, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4d4983535e97)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214143, encodeId=049622141437a, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=0a318129989' target=_blank style='color:#2F92EE;'>#肝癌風險#</a> <a href='/topic/show?id=a8e7852012' target=_blank style='color:#2F92EE;'>#HBsAg清除#</a> <a href='/topic/show?id=16fd1164520e' target=_blank style='color:#2F92EE;'>#PEG IFNα-2b#</a>, objectTitle=【期刊導讀】Paradise研究中期數(shù)據(jù)正式發(fā)表：加用聚乙二醇干擾素α治療肝癌中高風險的核苷經(jīng)治慢乙肝患者，可帶來雙重獲益, objectType=article, longId=830300, objectId=858c8303009f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240709/1720498682590_1608702.jpg, objectUrl=/article/show_article.do?id=858c8303009f, replyNumber=0, likeNumber=216, createdTime=2024-07-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=858c8303009f, moduleTitle=【期刊導讀】Paradise研究中期數(shù)據(jù)正式發(fā)表：加用聚乙二醇干擾素α治療肝癌中高風險的核苷經(jīng)治慢乙肝患者，可帶來雙重獲益, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=858c8303009f)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
